There is no commercial support for this activity.

About the speaker

Charles F. Reynolds III, MD, is internationally renowned in the field of geriatric psychiatry. His primary research interests focus on mood, grief, and sleep disorders of later life, with a particular focus on mental health services in primary care, improving treatment strategies, depression prevention, and promotion of brain health in older adults. In addition to his national presence, Dr. Reynolds cofounded the Global Consortium on Depression Prevention, a network of investigators in North America, Europe, Japan, Australia, and New Zealand. Currently, he leads an NIMH-sponsored project to develop scalable depression prevention strategies for use in low-resource countries. In this context, he travels annually to India to work with his team at the Goa Medical College. He has also served as a visiting professor in psychogeriatrics in the Netherlands, Brazil, India, Japan, the United Kingdom, France, Germany, Australia, and New Zealand, attesting to his now global impact on the field.

About the speaker

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Charles F. Reynolds, III, MD,  reports having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. He will not discuss any products or services in this presentation. This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on May 13, 2024. All conflicts have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.